Pathogenic role of glial cells in Parkinson's disease
- 28 October 2002
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 18 (2) , 121-129
- https://doi.org/10.1002/mds.10332
Abstract
An erratum for this article appears in the January, 2004 issue of Movement Disorders (Mov Disord 2004;19:119). Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of the dopaminergic neurons in the substantia nigra pars compacta (SNpc). The loss of these neurons is associated with a glial response composed mainly of activated microglial cells and, to a lesser extent, of reactive astrocytes. This glial response may be the source of trophic factors and can protect against reactive oxygen species and glutamate. Alternatively, this glial response can also mediate a variety of deleterious events related to the production of pro-oxidant reactive species, and pro-inflammatory prostaglandin and cytokines. We discuss the potential protective and deleterious effects of glial cells in the SNpc of PD and examine how those factors may contribute to the pathogenesis of this disease. © 2002 Movement Disorder SocietyKeywords
This publication has 81 references indexed in Scilit:
- Inhibition of brain‐derived neurotrophic factor and glial cell line‐derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatumEuropean Journal of Neuroscience, 2000
- Reply: a new look at the pathogenesis of Parkinson’s diseaseTrends in Pharmacological Sciences, 2000
- Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
- Ischemic Preconditioning and Brain Tolerance: Temporal Histological and Functional Outcomes, Protein Synthesis Requirement, and Interleukin-1 Receptor Antagonist and Early Gene ExpressionStroke, 1998
- Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's diseaseNeuroscience Letters, 1996
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- Microglia: Intrinsic immuneffector cell of the brainBrain Research Reviews, 1995
- REPLY FROM DRS. M. B. SPINA, S. P. SQUINTO, J. MILLER, R. M. LINDSAY, AND C. HYMANJournal of Neurochemistry, 1993
- Cytotoxicity of microgliaGlia, 1993
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983